Similar articles for PMID: 20889802

Year	Number of Results
1996	1
1997	1
1998	2
2000	1
2002	2
2003	3
2004	3
2005	2
2006	4
2008	3
2009	3
2010	3
2014	1
2016	1
2017	1
2019	1
2024	0

1

Finding the right target for treating Alzheimer disease.

Mandell BF. Mandell BF. Cleve Clin J Med. 2010 Oct;77(10):650. doi: 10.3949/ccjm.77b.10010. Cleve Clin J Med. 2010. PMID: 20889802 Free article. No abstract available.

2

Alzheimer disease prevention: focus on cardiovascular risk, not amyloid?

Geldmacher DS. Geldmacher DS. Cleve Clin J Med. 2010 Oct;77(10):689-704. doi: 10.3949/ccjm.77gr.2010. Cleve Clin J Med. 2010. PMID: 20889807 Free article.

3

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.

Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T. Bard F, et al. Nat Med. 2000 Aug;6(8):916-9. doi: 10.1038/78682. Nat Med. 2000. PMID: 10932230

4

[Molecular pathology and therapeutics in Alzheimer's disease: amyloid beta-protein as a therapeutic target].

Ohyagi Y. Ohyagi Y. Fukuoka Igaku Zasshi. 2006 Sep;97(9):261-8. Fukuoka Igaku Zasshi. 2006. PMID: 17134029 Free article. Review. Japanese. No abstract available.

5

Treating Alzheimer disease: Time matters.

Rosenberg RN. Rosenberg RN. Arch Neurol. 2006 Jul;63(7):926-8. doi: 10.1001/archneur.63.7.926. Arch Neurol. 2006. PMID: 16831959 No abstract available.

6

Interactions of Alzheimer amyloid peptides with cultured cells and brain tissue, and their biological consequences.

Bateman DA, Chakrabartty A. Bateman DA, et al. Biopolymers. 2004;76(1):4-14. doi: 10.1002/bip.10561. Biopolymers. 2004. PMID: 14997469 Review.

7

Peeling plaque. Researchers remain optimistic about a vaccine against Alzheimer's.

Martindale D. Martindale D. Sci Am. 2002 May;286(5):18, 20. Sci Am. 2002. PMID: 11951326 No abstract available.

8

Specificity of mechanisms for plaque removal after A beta immunotherapy for Alzheimer disease.

Akiyama H, McGeer PL. Akiyama H, et al. Nat Med. 2004 Feb;10(2):117-8; author reply 118-9. doi: 10.1038/nm0204-117. Nat Med. 2004. PMID: 14760408 No abstract available.

9

Amyloid-beta binding molecule: potential role in the pathogenesis and treatment of Alzheimer disease.

Holtzman DM. Holtzman DM. Alzheimer Dis Assoc Disord. 2003 Apr-Jun;17 Suppl 2:S66-8. Alzheimer Dis Assoc Disord. 2003. PMID: 12813214 Review. No abstract available.

10

Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden.

Kellner A, Matschke J, Bernreuther C, Moch H, Ferrer I, Glatzel M. Kellner A, et al. Ann Neurol. 2009 Jan;65(1):24-31. doi: 10.1002/ana.21475. Ann Neurol. 2009. PMID: 19194878 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year